Mizuho Securities Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Announces Target Price $55

Futu NewsDec 23 21:32 · Ratings

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT) and IDEAYA Biosciences (IDYA)

TipRanksDec 23 21:01 · Ratings

Companies Like IDEAYA Biosciences (NASDAQ:IDYA) Are In A Position To Invest In Growth

Simply Wall StDec 20 19:20

IDEAYA Biosciences (IDYA) Receives a Hold From Leerink Partners

TipRanksDec 18 13:37 · Ratings

RBC Capital Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $61

Futu NewsDec 18 01:31 · Ratings

Cantor Fitzgerald Reiterates Overweight on IDEAYA Biosciencesto Overweight

BenzingaDec 17 22:03